Financial Architects (New Jersey)’s Takeda Pharmaceutical TAK Stock Holding History

Financial Architects (New Jersey)’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-503	Closed	-$9K	–	711
2020 Q2	$9K	Hold	503	–	–	﹤0.01%	666
2020 Q1	$8K	Hold	503	–	–	﹤0.01%	658
2019 Q4	$10K	Hold	503	–	–	﹤0.01%	683
2019 Q3	$9K	Hold	503	–	–	﹤0.01%	745
2019 Q2	$9K	Hold	503	–	–	﹤0.01%	912
2019 Q1	$10K	Buy	+503	New	+$10.1K	﹤0.01%	1091

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Financial Architects (New Jersey)'s TAK Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of Takeda Pharmaceutical (TAK) in Q3 2020, closing a stake of 503 shares — an estimated $9K sold.

Financial Architects (New Jersey) first reported a position in TAK in Q1 2019 and held it in 6 quarters. The position peaked at $10K in Q4 2019. 311 funds tracked by Wall St. Rank hold TAK as of Q3 2020.

Financial Architects (New Jersey) reported no remaining Takeda Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 503 Takeda Pharmaceutical shares in Q3 2020, an estimated $9K.
Financial Architects (New Jersey) first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 6 quarters.
Financial Architects (New Jersey)'s Takeda Pharmaceutical position peaked at $10K in Q4 2019.
311 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.